On ECHEMI
Home > Drugs > Pulmonary coccidioidomycosis
Pulmonary coccidioidomycosis
Coccidioidomycosis is a fungal disease of the lungs or other organs caused by Coccidioides immitis. The lungs are the portal of entry for Coccidioidomycosis and the organ most commonly affected. Clinically, it is divided into primary and progressive. Primary is an acute, self-limited respiratory infection; progressive is a chronic, often fatal systemic infection.
  • Site of disease:

    lung
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Dry cough chest pain fever cough swollen lymph nodes
Related Drugs
Acetylspiramycin Capsules
Indication: It is suitable for mild and moderate infections caused by sensitive Staphylococci, Streptococci and Streptococcus pneumoniae, such as pharyngitis, tonsillitis, sinusitis, otitis media, periodontitis, acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, non-gonococcal urethritis, skin and soft tissue infections. It can also be used for cryptosporidiosis or as an optional drug for the treatment of toxoplasmosis in pregnant women.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.